Single Peptides · Exact presentation
Selank · 5 mg Vial
Selank · 5 mg Vial is an exact single peptide or compound entry. This strength is kept separate because concentration and calculations depend on vial amount.
Educational research information for this exact variation. It is not medical advice, a prescription, or proof of regulatory approval.
Separate commercial record
Availability in the Dominican Republic
This educational entry is separate from the live catalog. Check the exact commercial record for current availability, price, and lot documentation. View exact commercial record.
Dosing & Reconstitution Guide
For a 5 mg presentation, the reference concentration of 1.67 mg/mL mathematically corresponds to 2.994 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 1.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0167 mg at this concentration.
Selank 5 mg Nasal Spray Calculations
Selank · 5 mg Vial is an exact single peptide or compound entry. This strength is kept separate because concentration and calculations depend on vial amount.
How to Prepare the 5 mL or 10 mL Research Bottle
The evidence base may include regional studies, small trials, or preclinical models. Clinical generalization requires caution and verifiable primary sources.
Mathematical Actuator Equivalents
For a 5 mg presentation, the reference concentration of 1.67 mg/mL mathematically corresponds to 2.994 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 1.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0167 mg at this concentration.
Published Human Intranasal Selank Research
The evidence base may include regional studies, small trials, or preclinical models. Clinical generalization requires caution and verifiable primary sources.
Published Human Intranasal Selank Research
| Source | Research Context | Published Intranasal Amount and Formulation |
|---|---|---|
| Zozulia et al., 2008[1] | 62 adults with generalized anxiety disorder or neurasthenia | Selank 0.15% nasal drops at 2.7 mg per day, reported as 36 drops divided across three administrations, with outcomes followed through day 14. |
| Syunyakov et al., 2012[2] | 20 adults with generalized anxiety disorder | 2,700 mcg per day intranasally. The pharmaco-EEG analysis also examined a single 900 mcg exposure. |
| Panikratova et al., 2020[4] | Healthy-volunteer functional connectivity study | One intranasal exposure using 0.15% Selank solution, 60 microliters per nostril, described as a 0.2 mg total amount. |
Nasal Spray Actuator Math
For a 5 mg presentation, the reference concentration of 1.67 mg/mL mathematically corresponds to 2.994 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 1.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0167 mg at this concentration.
Core Formula
For a 5 mg presentation, the reference concentration of 1.67 mg/mL mathematically corresponds to 2.994 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 1.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0167 mg at this concentration.
Actuator Checks Before Recording a Result
For a 5 mg presentation, the reference concentration of 1.67 mg/mL mathematically corresponds to 2.994 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 1.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0167 mg at this concentration.
Research Amount Calculator
The evidence base may include regional studies, small trials, or preclinical models. Clinical generalization requires caution and verifiable primary sources.
Storage Instructions
Proper storage preserves peptide quality.
Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 1+ year.[5]
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks and avoid freeze–thaw.[6]
Allow vials to reach room temperature before opening to reduce condensation uptake.
How Intranasal Selank Research Works
The evidence base may include regional studies, small trials, or preclinical models. Clinical generalization requires caution and verifiable primary sources.
Human Research Findings and Observations
The evidence base may include regional studies, small trials, or preclinical models. Clinical generalization requires caution and verifiable primary sources.
Research Controls That Affect Nasal Delivery
The evidence base may include regional studies, small trials, or preclinical models. Clinical generalization requires caution and verifiable primary sources.
Nasal Actuator Technique
For a 5 mg presentation, the reference concentration of 1.67 mg/mL mathematically corresponds to 2.994 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 1.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0167 mg at this concentration.
Source trail
Scientific references and source discovery
- PeptideDosages — exact Selank · 5 mg Vial entrysecondary-structure
- PubMed — literature search for Selankprimary-discovery
- ClinicalTrials.gov — study search for Selanktrial-registry
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference